TradingMenu expanded
Forge Markets Browse Companies
DataMenu expanded
Forge Data Private Market Index IPO Stock Tracker
SolutionsMenu expanded
For Institutions For Shareholders For Investors For Companies In Europe
InsightsMenu expanded
All Insights Blog Glossary Reports Videos Webinars
Popular Topics
Buying Pre-IPO Shares Selling Pre-IPO Shares Private Market Updates Forge Investment Outlook Startup News
AboutMenu expanded
About Us Team Investor Relations People & Culture Careers FAQs
Log In Sign Up
Trading Menu expandedTrading
Forge Markets
Browse Companies
Data Menu expandedData
Forge Data
Private Market Index
IPO Stock Tracker
Solutions Menu expandedSolutions
For Institutions
For Shareholders
For Investors
For Companies
In Europe
Insights Menu expandedInsights
All Insights
Blog
Glossary
Reports
Videos
Webinars
Popular Topics
Buying Pre-IPO Shares
Selling Pre-IPO Shares
Private Market Updates
Forge Investment Outlook
Startup News
About Menu expandedAbout
About Us
Team
Investor Relations
People & Culture
Careers
FAQs
Trading / Browse Private Companies / Generate Biomedicines Stock

Generate Biomedicines Stock

generatebiomedicines.comHealthcare / BioTech & PharmaFounded: 2018Funding to Date: $686.67MM

Generate:Biomedicines, founded in 2018, is a biotechnology company and developer of a generative biology platform that seeks to use AI and machine learning to create pharmaceutical therapies on demand. Through its Generate Platform, the company aims to produce therapies for constantly changing clinical targets, with the goal of reducing the time and money required to respond to medical conditions. Generate:Biomedicines is headquartered in Somerville, Massachusetts.

Buy or sell Generate Biomedicines stockLearn more about Generate Biomedicines IPO

Register To Buy and Sell Shares

For more details on financing and valuation for Generate Biomedicines, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value

Powered by Forge Data

Access Generate Biomedicines’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Generate Biomedicines.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Register

Animation displayed is not current and securities are shown for illustrative purposes only.

Generate Biomedicines investors also invested in these private companies

Arch Venture Partners
Fidelity Management & Research
T. Rowe Price
Alaska Permanent Fund
Flagship Pioneering
Morningside Group
Amgen Ventures
Abu Dhabi Investment Authority
Altitude Life Science Ventures
NVentures
Partners Investment
March Capital
Maps Capital
Pictet Alternative Advisors

Team

Management Team

Jason Silvers
Chief Financial Officer
Gevorg Grigoryan Ph.D
Co-Founder & Chief Technology Officer
Beth Grous
Chief People Officer
Dimitris Agrafiotis Ph.D
Chief Digital Officer
Alexandra Snyder MD
Chief Medical Officer & Executive Vice President of Research & Development
Michael Nally
Co-Chief Executive Officer
Geoffrey von Maltzahn Ph.D
Co-Founder & Co-Chief Executive Officer
Molly Gibson Ph.D
Co-Founder & Chief Strategy and Innovation Officer
Sean Martin JD
Chief Legal Officer & General Counsel
Noubar Afeyan Ph.D
Co-Founder

Frequently Asked Questions About Generate Biomedicines’ Stock

plusminus
Can you buy Generate Biomedicines stock?
Generate Biomedicines is not publicly traded on NYSE or NASDAQ in the U.S. To buy Generate Biomedicines stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
plusminus
Can you sell Generate Biomedicines stock?
Yes, you can sell stock of a private company like Generate Biomedicines. Forge can help you sell your Generate Biomedicines stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
plusminus
What is Generate Biomedicines’ stock price?
Generate Biomedicines is a privately held company and therefore does not have a public stock price. However, you may access Generate Biomedicines’ private market stock price with Forge Data.
plusminus
What is Generate Biomedicines’ stock ticker symbol?
Generate Biomedicines does not have an official ticker symbol because this company is not currently publicly traded.
plusminus
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

Other companies like Generate Biomedicines in the BioTech & Pharma sector

Colossal Biosciences

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$1.01B

Altos Labs

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$3.67B

Tempus

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$8.7B

AI Therapeutics

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$110MM

Atomwise

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$405.17MM

Mammoth Biosciences

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$1.08B

Biosplice Therapeutics

Sector
Healthcare / BioTech & Pharma
 
 

Ginkgo Bioworks

Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$4.89B

Caris Life Sciences

Sector
Healthcare / BioTech & Pharma
 
 

News Highlights

BioSpace 09/14/2023
Generate Raises $273M in Series C Financing with New Investors Amgen, NVIDIA
AI-focused startup Generate:Biomedicines has raised $273 million in Series C financing with new investors including Amgen and NVIDIA’s venture capital arm, the Massachusetts-based biotech announced Thursday.

Trending Companies

Frequently Asked Questions

Updated on: Dec 3, 2023

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.